Showing results (781-790 of 1,166) with videos related to

Sort By:
Pageof 117
Regional Anesthesia and Pain Medicine|October 31, 2024
Continuous peripheral nerve blocks for burn management: a retrospective study of outcomes and complications in 281 burn patientsLouis Perkins, Gerardo Pedroza, Max Soghikian, et al.
Patient Education and Counseling|June 6, 2022
Bringing personal perspective elicitation to the heart of shared decision-making: A scoping reviewEster A Rake, Ivana C H Box, Dunja Dreesens, et al.
Magnetic Resonance in Medicine|May 6, 2017
Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3TSamantha By, Robert L Barry, Alex K Smith, et al.
Biochimica Et Biophysica Acta|June 4, 1999
Assay for reactive oxygen species-induced DNA damage: measurement of the formamido and thymine glycol lesionsA E Maccubbin, H B Patrzyc, N Ersing, et al.
Yeast (Chichester, England)|August 1, 2008
Carbohydrate utilization and the lager yeast transcriptome during brewery fermentationBrian R Gibson, Chris A Boulton, Wendy G Box, et al.
MMWR. Morbidity and Mortality Weekly Report|May 9, 2014
Expanding primary care capacity to treat hepatitis C virus infection through an evidence-based care model--Arizona and Utah, 2012-2014Kiren Mitruka, Karla Thornton, Susanne Cusick, et al.
Neuroimage|July 22, 2019
Diffusion MRI microstructural models in the cervical spinal cord - Application, normative values, and correlations with histological analysisKurt G Schilling, Samantha By, Haley R Feiler, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2015
Characterisation of selected active agents regarding pKa values, solubility concentrations and pH profiles by SiriusT3D Schönherr, U Wollatz, D Haznar-Garbacz, et al.
Cancer Research|April 11, 2015
TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor ImmunityClaire Vanpouille-Box, Julie M Diamond, Karsten A Pilones, et al.
Annals of the Rheumatic Diseases|November 19, 2008
Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD studyR Fleischmann, J Vencovsky, R F van Vollenhoven, et al.
Pageof 117